QW Dose of IQVIA: Weekly US Script Tracker

Research evidence excerpt

QW Dose of IQVIA: Weekly US Script Tracker

Pharmaceuticals (Major) & Large Cap Biotechnology

QW Dose of IQVIA: Weekly US Script Tracker June 26, 2026

Scripts for the week ending June 19th. We saw another relatively red week in

the IQVIA data this morning, which we'd attribute to the shorter business week in

observance of Juneteenth. Total scripts for the newly launched oral AOMs were down

week over week, with Wegovy pill falling -5.9% and Foundayo -4.9%. However,

modest Zepbound growth was observed. No one-timers from IQVIA to call out this Alexandria Hammond

week. ahammond@wolferesearch.com

(646) 582-9320

View Alexandria’s Research

Exhibit 1 - Product Script Evolution Overview View Comp Table

TRx TRx Weekly Change NRx NRx Weekly Change Hannah Tran Drug

(this week) (last week) in TRx (this week) (last week) in NRx htran@wolferesearch.com

Type II Diabetes (646) 582-9391

Mounjaro (LLY) 804,319 804,502 0.0% 383,833 384,598 -0.2%

Cameron DeGuzman

Ozempic (NOVO) 515,370 518,065 -0.5% 219,885 220,601 -0.3% cdeguzman@wolferesearch.com

Chronic weight management 646-582-9324

Zepbound (LLY) 658,942 649,813 1.4% 357,869 353,405 1.3%

AI Wegovy (NOVO) 314,726 313,685 0.3% 189,969 193,210 -1.7%

Wegovy Pill (NOVO) 151,963 161,525 -5.9% 121,646 132,886 -8.5%

Foundayo (LLY) 20,594 21,648 -4.9% 18,926 19,895 -4.9%

HIV treatments and PrEP for HIV

Biktarvy (GILD) 58,680 59,944 -2.1% 19,102 19,527 -2.2%

Descovy (GILD) 37,238 38,385 -3.0% 16,901 16,905 0.0%

Yeztugo (GILD) 887 980 -9.5% 763 843 -9.5%

Apretude (GSK1) 2,612 3,048 -14.3% 1,217 1,459 -16.6%

Inflammation and immunology

Humira (ABBV) 17,523 18,486 -5.2% 4,792 4,895 -2.1%

Skyrizi (ABBV) 26,015 26,351 -1.3% 11,532 11,730 -1.7%

Rinvoq (ABBV) 32,272 31,911 1.1% 9,866 9,322 5.8%

Dupixent (REGN) 102,108 107,812 -5.3% 25,993 27,090 -4.0%